Kinnate Biopharma
AcquiredUnited States · $146.0M raised
- Business Model
- B2B
- Website
- kinnate.com
- Total Funding
- $146.0M
- Last Round
- $98.0M Series CAug 2020
- Rounds
- 2
About
Clinical-stage precision oncology company.
Summary
Kinnate Biopharma is a Biotech company based in United States. It has raised $146.0M in total across 2 rounds, most recently a $98.0M Series C round in Aug 2020.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...